Alexander J. Lazar

142.1k total citations · 7 hit papers
448 papers, 21.1k citations indexed

About

Alexander J. Lazar is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Alexander J. Lazar has authored 448 papers receiving a total of 21.1k indexed citations (citations by other indexed papers that have themselves been cited), including 257 papers in Pulmonary and Respiratory Medicine, 181 papers in Oncology and 125 papers in Molecular Biology. Recurrent topics in Alexander J. Lazar's work include Sarcoma Diagnosis and Treatment (225 papers), Vascular Tumors and Angiosarcomas (61 papers) and Cardiac tumors and thrombi (56 papers). Alexander J. Lazar is often cited by papers focused on Sarcoma Diagnosis and Treatment (225 papers), Vascular Tumors and Angiosarcomas (61 papers) and Cardiac tumors and thrombi (56 papers). Alexander J. Lazar collaborates with scholars based in United States, Canada and United Kingdom. Alexander J. Lazar's co-authors include Dina Lev, Wei‐Lien Wang, Raphael E. Pollock, Dolores López‐Terrada, Jeffrey E. Gershenwald, Elizabeth G. Demicco, Michael A. Davies, Víctor G. Prieto, Guy Lahat and Eduardo Calonje and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Alexander J. Lazar

426 papers receiving 20.8k citations

Hit Papers

Melanoma staging: Evidence‐based changes in the Amer... 2011 2026 2016 2021 2017 2018 2020 2011 2012 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
    2017 1.4k citations Jeffrey E. Gershenwald, Alexander J. Lazar et al. profile →
  2. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
    2018 608 citations Alexander J. Lazar et al. profile →
  3. The 2019 World Health Organization classification of tumours of the breast
    2020 547 citations Alexander J. Lazar et al. Histopathology profile →
  4. NRAS mutation status is an independent prognostic factor in metastatic melanoma
    2011 528 citations Roland L. Bassett, Chaan S. Ng et al. profile →
  5. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model
    2012 352 citations Elizabeth G. Demicco, Patricia S. Fox et al. Modern Pathology profile →
  6. Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model
    2017 242 citations Elizabeth G. Demicco, Alexander J. Lazar et al. Modern Pathology profile →
  7. McKee's pathology of the skin: with clinical correlations
    2012 108 citations Eduardo Calonje, Alexander J. Lazar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander J. Lazar United States 77 9.2k 8.9k 6.5k 4.0k 3.5k 448 21.1k
Jason L. Hornick United States 82 11.6k 1.3× 8.3k 0.9× 4.5k 0.7× 7.0k 1.7× 4.7k 1.4× 487 24.8k
Yoshinao Oda Japan 64 7.7k 0.8× 8.7k 1.0× 6.3k 1.0× 2.3k 0.6× 2.4k 0.7× 948 20.4k
Antoîne Italiano France 67 9.2k 1.0× 9.0k 1.0× 4.0k 0.6× 2.3k 0.6× 2.6k 0.7× 618 17.5k
Silvana Pilotti Italy 68 5.3k 0.6× 6.6k 0.7× 5.1k 0.8× 2.3k 0.6× 2.7k 0.8× 294 16.2k
Jae Y. Ro United States 83 10.4k 1.1× 7.6k 0.9× 6.6k 1.0× 4.3k 1.1× 2.9k 0.8× 595 24.2k
Robert G. Maki United States 88 18.3k 2.0× 9.7k 1.1× 3.9k 0.6× 3.7k 0.9× 3.3k 0.9× 377 26.3k
Olivier Delattre France 82 9.2k 1.0× 6.2k 0.7× 13.8k 2.1× 2.2k 0.5× 5.2k 1.5× 414 26.1k
Angelo Paolo Dei Tos Italy 67 10.9k 1.2× 6.1k 0.7× 2.5k 0.4× 4.5k 1.1× 2.9k 0.8× 438 17.0k
Brian P. Rubin United States 67 11.1k 1.2× 4.2k 0.5× 3.6k 0.6× 3.7k 0.9× 2.4k 0.7× 275 19.2k
Piero Picci Italy 84 16.8k 1.8× 6.8k 0.8× 6.5k 1.0× 9.6k 2.4× 2.7k 0.8× 562 25.4k

Countries citing papers authored by Alexander J. Lazar

Since Specialization
Citations

This map shows the geographic impact of Alexander J. Lazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander J. Lazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander J. Lazar more than expected).

Fields of papers citing papers by Alexander J. Lazar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander J. Lazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander J. Lazar. The network helps show where Alexander J. Lazar may publish in the future.

Co-authorship network of co-authors of Alexander J. Lazar

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander J. Lazar. A scholar is included among the top collaborators of Alexander J. Lazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander J. Lazar. Alexander J. Lazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lazcano, Rossana, et al.. (2024). TRPS1 expression in MPNST is correlated with PRC2 inactivation and loss of H3K27me3. Human Pathology. 151. 105632–105632.
2.
Macêdo, Mariana Petaccia de, Fernando C. L. Carapeto, Feng Wang, et al.. (2023). Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma. Journal of Investigative Dermatology. 143(9). 1779–1787.e1. 3 indexed citations
3.
Denu, Ryan A., Justin T. Moyers, Mohamed A. Gouda, et al.. (2023). The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database: Clinical Implications. Clinical Cancer Research. 29(22). 4669–4678. 4 indexed citations
4.
Ronen, Shira, Jennifer S. Ko, Brian P. Rubin, et al.. (2022). Superficial low‐grade fibromyxoid sarcoma. Journal of Cutaneous Pathology. 50(2). 147–154. 6 indexed citations
5.
Dodd, Rebecca D., Chang‐Lung Lee, Wesley Huang, et al.. (2017). NF1+/− Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy Response. Cancer Research. 77(16). 4486–4497. 21 indexed citations
6.
Goswami, Rashmi S., Keyur P. Patel, Rajesh R. Singh, et al.. (2015). Hotspot Mutation Panel Testing Reveals Clonal Evolution in a Study of 265 Paired Primary and Metastatic Tumors. Clinical Cancer Research. 21(11). 2644–2651. 59 indexed citations
7.
Chen, Guo, Nitin Chakravarti, Kimberly Aardalen, et al.. (2014). Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target. Clinical Cancer Research. 20(21). 5537–5546. 120 indexed citations
8.
Bucheit, Amanda D., Guo Chen, Alan Siroy, et al.. (2014). Complete Loss of PTEN Protein Expression Correlates with Shorter Time to Brain Metastasis and Survival in Stage IIIB/C Melanoma Patients with BRAF V600 Mutations. Clinical Cancer Research. 20(21). 5527–5536. 109 indexed citations
9.
Wang, Wei‐Lien, et al.. (2012). CTNNB1 Genotyping and APC Screening in Pediatric Desmoid Tumors: A Proposed Algorithm. Pediatric and Developmental Pathology. 15(5). 361–367. 34 indexed citations
10.
Davies, Michael A., Patricia S. Fox, Nicholas E. Papadopoulos, et al.. (2012). Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma. Clinical Cancer Research. 18(4). 1120–1128. 39 indexed citations
11.
Zhang, Pingyu, Katelynn Bill, Juehui Liu, et al.. (2012). MiR-155 Is a Liposarcoma Oncogene That Targets Casein Kinase-1α and Enhances β-Catenin Signaling. Cancer Research. 72(7). 1751–1762. 100 indexed citations
12.
Yang, Jinming, Sara Kantrow, Jiqing Sai, et al.. (2012). Ikk4a/Arf Inactivation with Activation of the NF-κB/IL-6 Pathway Is Sufficient to Drive the Development and Growth of Angiosarcoma. Cancer Research. 72(18). 4682–4695. 30 indexed citations
13.
Ghadimi, Markus P., Eric D. Young, Roman Belousov, et al.. (2012). Survivin Is a Viable Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors. Clinical Cancer Research. 18(9). 2545–2557. 36 indexed citations
14.
Savannah, Kari J. Brewer, Elizabeth G. Demicco, Kristelle Lusby, et al.. (2012). Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma. Clinical Cancer Research. 18(17). 4633–4645. 40 indexed citations
15.
Xie, Xianbiao, Markus P. Ghadimi, Eric D. Young, et al.. (2011). Combining EGFR and mTOR Blockade for the Treatment of Epithelioid Sarcoma. Clinical Cancer Research. 17(18). 5901–5912. 34 indexed citations
16.
Torres, Keila E., Quansheng Zhu, Katelynn Bill, et al.. (2011). Activated MET Is a Molecular Prognosticator and Potential Therapeutic Target for Malignant Peripheral Nerve Sheath Tumors. Clinical Cancer Research. 17(12). 3943–3955. 74 indexed citations
17.
Lazar, Alexander J., et al.. (2009). Desmoid tumor: from surgical extirpation to molecular dissection. Current Opinion in Oncology. 21(4). 352–359. 36 indexed citations
18.
Prieto, Víctor G., Jason W. Nash, Doina Ivan, et al.. (2008). Metastatic basal cell carcinoma exhibits reduced actin expression. Modern Pathology. 21(5). 540–543. 29 indexed citations
19.
Ren, Wenhong, Borys Korchin, Quansheng Zhu, et al.. (2008). Epidermal Growth Factor Receptor Blockade in Combination with Conventional Chemotherapy Inhibits Soft Tissue Sarcoma Cell Growth In vitro and In vivo. Clinical Cancer Research. 14(9). 2785–2795. 33 indexed citations
20.
Carr, Richard, et al.. (2007). Characteristic Ber‐EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma. Histopathology. 51(1). 80–86. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason L. Hornick Breakdown of academic impact, for papers by Yoshinao Oda Breakdown of academic impact, for papers by Antoîne Italiano Breakdown of academic impact, for papers by Silvana Pilotti Breakdown of academic impact, for papers by Jae Y. Ro Breakdown of academic impact, for papers by Robert G. Maki Breakdown of academic impact, for papers by Olivier Delattre Breakdown of academic impact, for papers by Angelo Paolo Dei Tos Breakdown of academic impact, for papers by Brian P. Rubin Breakdown of academic impact, for papers by Piero Picci
Rankless by CCL
2026